Verona Pharma plc - American Depositary Share Stock Price, News & Analysis (NASDAQ:VRNA)

$11.88 -0.04 (-0.34 %)
(As of 12/17/2017 04:00 PM ET)
Previous Close$11.88
Today's Range$11.43 - $12.44
52-Week Range$10.44 - $17.50
Volume19,266 shs
Average Volume3,215 shs
Market Capitalization$155.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Verona Pharma plc - American Depositary Share (NASDAQ:VRNA)

Verona Pharma plc - American Depositary Share logoVerona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company’s lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.

Receive VRNA News and Ratings via Email

Sign-up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VRNA
CUSIPN/A
Phone44-20-3283-4200

Debt

Debt-to-Equity RatioN/A
Current Ratio10.48%
Quick Ratio10.48%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees12
Outstanding Shares13,110,000

Verona Pharma plc - American Depositary Share (NASDAQ:VRNA) Frequently Asked Questions

What is Verona Pharma plc - American Depositary Share's stock symbol?

Verona Pharma plc - American Depositary Share trades on the NASDAQ under the ticker symbol "VRNA."

Where is Verona Pharma plc - American Depositary Share's stock going? Where will Verona Pharma plc - American Depositary Share's stock price be in 2017?

4 brokers have issued 12 month target prices for Verona Pharma plc - American Depositary Share's shares. Their forecasts range from $22.00 to $33.00. On average, they expect Verona Pharma plc - American Depositary Share's stock price to reach $26.75 in the next twelve months. View Analyst Ratings for Verona Pharma plc - American Depositary Share.

Who are some of Verona Pharma plc - American Depositary Share's key competitors?

When did Verona Pharma plc - American Depositary Share IPO?

(VRNA) raised $61 million in an initial public offering on Thursday, April 27th 2017. The company issued 4,500,000 shares at a price of $13.49 per share. Jefferies and Stifel acted as the underwriters for the IPO and Wedbush PacGrow and SunTrust Robinson Humphrey were co-managers.

When did the company's lock-up period expire?

Verona Pharma plc - American Depositary Share's lock-up period expired on Tuesday, October 24th. Verona Pharma plc - American Depositary Share had issued 5,768,000 shares in its public offering on April 27th. The total size of the offering was $77,868,000 based on an initial share price of $13.50. Since the end of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

How do I buy Verona Pharma plc - American Depositary Share stock?

Shares of Verona Pharma plc - American Depositary Share can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Verona Pharma plc - American Depositary Share's stock price today?

One share of Verona Pharma plc - American Depositary Share stock can currently be purchased for approximately $11.88.

How big of a company is Verona Pharma plc - American Depositary Share?

Verona Pharma plc - American Depositary Share has a market capitalization of $155.76 million. Verona Pharma plc - American Depositary Share employs 12 workers across the globe.

How can I contact Verona Pharma plc - American Depositary Share?

Verona Pharma plc - American Depositary Share's mailing address is 3 MORE LONDON RIVERSIDE, LONDON X0, SE1 2RE. The company can be reached via phone at 44-20-3283-4200 or via email at [email protected]


MarketBeat Community Rating for Verona Pharma plc - American Depositary Share (VRNA)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  100
MarketBeat's community ratings are surveys of what our community members think about Verona Pharma plc - American Depositary Share and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Verona Pharma plc - American Depositary Share (NASDAQ:VRNA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.75$26.75$26.75$24.75
Price Target Upside: 135.06% upside60.56% upside60.56% upside83.06% upside

Verona Pharma plc - American Depositary Share (NASDAQ:VRNA) Consensus Price Target History

Price Target History for Verona Pharma plc - American Depositary Share (NASDAQ:VRNA)

Verona Pharma plc - American Depositary Share (NASDAQ:VRNA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/8/2017WedbushReiterated RatingBuy$33.00LowView Rating Details
5/22/2017Jefferies GroupReiterated RatingBuy$26.00HighView Rating Details
5/22/2017SunTrust BanksInitiated CoverageBuy -> Buy$26.00HighView Rating Details
5/22/2017Stifel NicolausInitiated CoverageBuy -> Buy$22.00HighView Rating Details
(Data available from 12/17/2015 forward)

Earnings

Verona Pharma plc - American Depositary Share (NASDAQ:VRNA) Earnings History and Estimates Chart

Earnings by Quarter for Verona Pharma plc - American Depositary Share (NASDAQ:VRNA)

Verona Pharma plc - American Depositary Share (NASDAQ VRNA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/20176/30/2017($0.28)($0.37)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Verona Pharma plc - American Depositary Share (NASDAQ:VRNA) Earnings Estimates

2017 EPS Consensus Estimate: ($1.62)
2018 EPS Consensus Estimate: ($2.19)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172($0.35)($0.06)($0.21)
Q2 20172($0.31)($0.26)($0.29)
Q3 20173($0.58)($0.42)($0.51)
Q4 20173($0.75)($0.43)($0.62)
Q1 20182($0.73)($0.44)($0.59)
Q2 20182($0.70)($0.46)($0.58)
Q3 20182($0.51)($0.48)($0.50)
Q4 20182($0.56)($0.50)($0.53)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Verona Pharma plc - American Depositary Share (NASDAQ:VRNA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Verona Pharma plc - American Depositary Share (NASDAQ VRNA)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Verona Pharma plc - American Depositary Share (NASDAQ VRNA) News Headlines

Source:
DateHeadline
Verona Pharma PLC American Depositary Share (VRNA) Stock Rating Reaffirmed by WedbushVerona Pharma PLC American Depositary Share (VRNA) Stock Rating Reaffirmed by Wedbush
www.americanbankingnews.com - December 8 at 4:40 PM
Zacks: Brokerages Set $26.75 Target Price for Verona Pharma PLC American Depositary Share (VRNA)Zacks: Brokerages Set $26.75 Target Price for Verona Pharma PLC American Depositary Share (VRNA)
www.americanbankingnews.com - December 5 at 7:50 PM
Verona Pharma plc : PDMR DealingVerona Pharma plc : PDMR Dealing
finance.yahoo.com - November 30 at 9:09 AM
Zacks: Brokerages Set $26.75 Price Target for Verona Pharma PLC American Depositary Share (VRNA)Zacks: Brokerages Set $26.75 Price Target for Verona Pharma PLC American Depositary Share (VRNA)
www.americanbankingnews.com - November 19 at 1:38 PM
Verona Pharma PLC American Depositary Share (VRNA) to Post FY2017 Earnings of ($2.91) Per Share, Jefferies Group ForecastsVerona Pharma PLC American Depositary Share (VRNA) to Post FY2017 Earnings of ($2.91) Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - November 10 at 12:41 PM
Verona Pharma PLC American Depositary Share (VRNA) Downgraded by Zacks Investment ResearchVerona Pharma PLC American Depositary Share (VRNA) Downgraded by Zacks Investment Research
www.americanbankingnews.com - November 10 at 8:37 AM
Verona Pharma PLC American Depositary Share to Post FY2020 Earnings of $4.31 Per Share, Jefferies Group Forecasts (VRNA)Verona Pharma PLC American Depositary Share to Post FY2020 Earnings of $4.31 Per Share, Jefferies Group Forecasts (VRNA)
www.americanbankingnews.com - November 9 at 4:02 PM
FY2017 Earnings Estimate for Verona Pharma PLC American Depositary Share Issued By SunTrust Banks (VRNA)FY2017 Earnings Estimate for Verona Pharma PLC American Depositary Share Issued By SunTrust Banks (VRNA)
www.americanbankingnews.com - November 9 at 6:22 AM
Zacks: Verona Pharma PLC American Depositary Share (VRNA) Given Consensus Recommendation of "Strong Buy" by AnalystsZacks: Verona Pharma PLC American Depositary Share (VRNA) Given Consensus Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - November 4 at 3:38 AM
Should You Buy Verona Pharma plc (AIM:VRP)?Should You Buy Verona Pharma plc (AIM:VRP)?
finance.yahoo.com - October 28 at 8:23 AM
[$$] Small-cap focus: UK life sciences groups look across Atlantic[$$] Small-cap focus: UK life sciences groups look across Atlantic
finance.yahoo.com - October 20 at 4:30 PM
 Verona Pharma PLC American Depositary Share (VRNA) Receives Average Recommendation of "Strong Buy" from Brokerages Verona Pharma PLC American Depositary Share (VRNA) Receives Average Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - October 20 at 6:44 AM
Verona Pharma PLC American Depositary Shares Lock-Up Period To End  on October 24th (NASDAQ:VRNA)Verona Pharma PLC American Depositary Share's Lock-Up Period To End on October 24th (NASDAQ:VRNA)
www.americanbankingnews.com - October 17 at 1:06 AM
Zacks: Verona Pharma PLC American Depositary Share (VRNA) Given $26.75 Average Price Target by BrokeragesZacks: Verona Pharma PLC American Depositary Share (VRNA) Given $26.75 Average Price Target by Brokerages
www.americanbankingnews.com - October 5 at 12:20 PM
Verona Pharma PLC American Depositary Shares (VRNA) "Outperform" Rating Reiterated at WedbushVerona Pharma PLC American Depositary Share's (VRNA) "Outperform" Rating Reiterated at Wedbush
www.americanbankingnews.com - September 8 at 10:44 AM
Brokerages Expect Verona Pharma PLC American Depositary Share (VRNA) to Announce ($0.51) EPSBrokerages Expect Verona Pharma PLC American Depositary Share (VRNA) to Announce ($0.51) EPS
www.americanbankingnews.com - August 17 at 4:48 AM
Q3 2017 Earnings Estimate for Verona Pharma PLC American Depositary Share (VRNA) Issued By WedbushQ3 2017 Earnings Estimate for Verona Pharma PLC American Depositary Share (VRNA) Issued By Wedbush
www.americanbankingnews.com - August 16 at 6:26 AM
Q3 2017 EPS Estimates for Verona Pharma PLC American Depositary Share (VRNA) Cut by AnalystQ3 2017 EPS Estimates for Verona Pharma PLC American Depositary Share (VRNA) Cut by Analyst
www.americanbankingnews.com - August 11 at 7:48 AM
Equities Analysts Issue Forecasts for Verona Pharma PLC American Depositary Shares Q3 2017 Earnings (NASDAQ:VRNA)Equities Analysts Issue Forecasts for Verona Pharma PLC American Depositary Share's Q3 2017 Earnings (NASDAQ:VRNA)
www.americanbankingnews.com - August 10 at 7:56 AM
Verona Pharma PLC American Depositary Share (VRNA) Announces  Earnings Results, Misses Estimates By $0.10 EPSVerona Pharma PLC American Depositary Share (VRNA) Announces Earnings Results, Misses Estimates By $0.10 EPS
www.americanbankingnews.com - August 8 at 3:30 PM
Verona Pharma plc Interim Results for the Six Months Ended June 30, 2017 and Clinical Development UpdateVerona Pharma plc Interim Results for the Six Months Ended June 30, 2017 and Clinical Development Update
finance.yahoo.com - August 8 at 8:08 AM
Verona Pharma PLC American Depositary Share (VRNA) Expected to Post Earnings of -$0.28 Per ShareVerona Pharma PLC American Depositary Share (VRNA) Expected to Post Earnings of -$0.28 Per Share
www.americanbankingnews.com - August 4 at 6:26 PM
Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) Scheduled to Post Earnings on TuesdayVerona Pharma PLC American Depositary Share (NASDAQ:VRNA) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - August 4 at 3:32 PM
Verona Pharma Doses First Patients in Phase 2b Clinical Trial of RPL554 for COPD Maintenance TreatmentVerona Pharma Doses First Patients in Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment
finance.yahoo.com - July 26 at 9:48 AM
 Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) Given $24.75 Consensus Target Price by Brokerages Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) Given $24.75 Consensus Target Price by Brokerages
www.americanbankingnews.com - July 11 at 5:04 PM

SEC Filings

Verona Pharma plc - American Depositary Share (NASDAQ:VRNA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Verona Pharma plc - American Depositary Share (NASDAQ:VRNA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Verona Pharma plc - American Depositary Share (NASDAQ VRNA) Stock Chart for Sunday, December, 17, 2017

Loading chart…

This page was last updated on 12/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.